We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: heart failure
MedXY News
EnglishTag

heart failure

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Beyond the Gradient: Invasive Exercise Hemodynamics Confirm Discordant Low-Gradient Aortic Stenosis as a High-Risk Phenotype
Cardiologyaortic stenosisCardiology

Beyond the Gradient: Invasive Exercise Hemodynamics Confirm Discordant Low-Gradient Aortic Stenosis as a High-Risk Phenotype

By MedXY|Mar 9, 2026

A pivotal study using invasive exercise hemodynamics reveals that discordant low-gradient aortic stenosis behaves similarly to high-gradient severe disease, often masking underlying heart failure with preserved ejection fraction (HFpEF) phy

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography
AIartificial intelligenceECG

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography

By MedXY|Mar 9, 2026

This review evaluates the breakthrough ECG2HF model, a publicly available AI tool that outperforms standard clinical scores in predicting 10-year heart failure risk using 12-lead ECG waveforms.

Genotype-Phenotype Divergence in Hypertrophic Cardiomyopathy: Deciphering the Trajectories of Sarcomeric and Nonsarcomeric Disease
Cardiologygeneticsheart failure

Genotype-Phenotype Divergence in Hypertrophic Cardiomyopathy: Deciphering the Trajectories of Sarcomeric and Nonsarcomeric Disease

By MedXY|Mar 9, 2026

This review analyzes the SHaRe registry data, revealing that sarcomeric HCM represents a more aggressive clinical phenotype with earlier onset and higher HCM-related mortality compared to nonsarcomeric cases, which are more heavily influenc

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis
Cardiologyheart failureTransthyretin Cardiac Amyloidosis

Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis

By MedXY|Mar 7, 2026

This large retrospective study of 820 patients reveals that restrictive ventricular physiology is the most common phenotype in cardiac amyloidosis. While preserved LV function offers better initial survival, the rate of progression to restr

MUTTON-HF: Can Reclaiming Indigenous Food Systems Reduce Heart Failure Readmissions?
Cardiologyheart failureThực Phẩm là Thuốc

MUTTON-HF: Can Reclaiming Indigenous Food Systems Reduce Heart Failure Readmissions?

By MedXY|Mar 6, 2026

The MUTTON-HF trial evaluates whether culturally and medically tailored meals, incorporating traditional Diné (Navajo) foods, can improve clinical outcomes and quality of life for Indigenous heart failure patients facing nutrition insecurit

Prognostic Significance of Dephospho-Uncarboxylated Matrix Gla-Protein in Heart Failure: Insights into Vascular Calcification and Therapeutic Implications
Cardiologybiomarkersheart failure

Prognostic Significance of Dephospho-Uncarboxylated Matrix Gla-Protein in Heart Failure: Insights into Vascular Calcification and Therapeutic Implications

By MedXY|Mar 5, 2026

A large-scale cohort study identifies dpucMGP as a robust predictor of mortality and hospitalization in heart failure, revealing its role in mediating warfarin-associated risks and its association with systemic proteomic pathways including

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Prognostic Impact Varies Significantly by Subtype
CardiologyCardiologyheart failure

Rethinking Mitral Regurgitation in Hypertrophic Cardiomyopathy: Prognostic Impact Varies Significantly by Subtype

By MedXY|Mar 3, 2026

The REVEAL-HCM study demonstrates that while mitral regurgitation is a frequent comorbidity in hypertrophic cardiomyopathy, its prognostic impact is highly subtype-specific, significantly affecting outcomes in non-obstructive subtypes but s

Insulin Resistance Blunts LVAD-Mediated Myocardial Recovery by Impairing the Pentose Phosphate Pathway
Cardiologyheart failureinsulin resistance

Insulin Resistance Blunts LVAD-Mediated Myocardial Recovery by Impairing the Pentose Phosphate Pathway

By MedXY|Mar 2, 2026

Obesity-induced insulin resistance hinders heart failure recovery post-LVAD by disrupting the pentose phosphate pathway. A new study in Circulation suggests insulin sensitizers could restore cardiac repair mechanisms in obese patients.

The Hemodynamic Paradox of Valve-in-Valve TAVR: Redefining ‘Optimal’ Gradients and Patient-Prosthesis Mismatch
Cardiologyaortic stenosisheart failure

The Hemodynamic Paradox of Valve-in-Valve TAVR: Redefining ‘Optimal’ Gradients and Patient-Prosthesis Mismatch

By MedXY|Mar 2, 2026

This review analyzes new registry data revealing that low discharge gradients (<10 mm Hg) after balloon-expandable ViV-TAVR correlate with reduced LVEF and higher 5-year mortality, challenging conventional hemodynamic success metrics.

Beyond the Restrictive Paradigm: Redefining Left Ventricular Phenotypes and Prognosis in Cardiac Amyloidosis
Cardiologyechocardiographyheart failure

Beyond the Restrictive Paradigm: Redefining Left Ventricular Phenotypes and Prognosis in Cardiac Amyloidosis

By MedXY|Mar 2, 2026

A large-scale retrospective study challenges the classic view of cardiac amyloidosis, revealing that while restriction is the dominant phenotype at diagnosis, nearly one-third of patients present with preserved function, and progression pat

PRMT9 and Heart Recovery: A New Frontier in Macrophage Modulation and STAT1 Degradation
Cardiologyheart failureinflammation

PRMT9 and Heart Recovery: A New Frontier in Macrophage Modulation and STAT1 Degradation

By MedXY|Mar 2, 2026

Researchers have discovered that the protein PRMT9 plays a vital role in healing the heart after a myocardial infarction by controlling inflammatory macrophages. By promoting the degradation of the STAT1 protein, PRMT9 reduces tissue damage

Obesity Severity and Cardiovascular Trajectories: Insights from the Cross-Cohort Collaboration
Cardiologycardiovascular diseaseheart failure

Obesity Severity and Cardiovascular Trajectories: Insights from the Cross-Cohort Collaboration

By MedXY|Mar 2, 2026

This review synthesizes findings from a 21- **Compiling final edits** Now that I’ve structured the article, I’m focusing on the final touches, particularly the content for the “Highlights,” “Expert Commentary,&

AKI and Diuretic Resistance: Identifying the High-Risk Phenotype in SCAI Stage B Cardiogenic Shock
Cardiologyacute kidney injurycardiogenic shock

AKI and Diuretic Resistance: Identifying the High-Risk Phenotype in SCAI Stage B Cardiogenic Shock

By MedXY|Mar 2, 2026

New research highlights that nearly a quarter of SCAI Stage B cardiogenic shock patients deteriorate. Acute kidney injury and diuretic resistance serve as critical early warning signs, providing clinicians a window for proactive interventio

Restrictive Physiology, Not Systolic Failure, Defines the Clinical Landscape of Cardiac Amyloidosis
Cardiologyechocardiographyheart failure

Restrictive Physiology, Not Systolic Failure, Defines the Clinical Landscape of Cardiac Amyloidosis

By MedXY|Mar 2, 2026

A large-scale study identifies restrictive physiology as the dominant phenotype in cardiac amyloidosis. While preserved function offers better survival, rapid progression to restriction underscores the importance of early diagnosis and moni

Heart Failure Prevention in Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT-2 and DPP-4 Inhibitors
Clinical UpdatesGLP-1RAheart failure

Heart Failure Prevention in Type 2 Diabetes: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT-2 and DPP-4 Inhibitors

By MedXY|Mar 2, 2026

A large-scale target trial emulation demonstrates that GLP-1RAs significantly reduce heart failure hospitalization risks compared to DPP-4 inhibitors and provide comparable protection to SGLT-2 inhibitors in routine clinical practice.

AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy
AIartificial intelligenceheart failure

AI-Enabled Stethoscopes in Primary Care: Why Implementation Science Matters More Than Algorithm Accuracy

By MedXY|Mar 2, 2026

The TRICORDER trial demonstrates that while AI stethoscopes are capable of detecting heart failure, atrial fibrillation, and valvular disease, their real-world implementation in UK primary care did not yield a statistically significant incr

Healing the Heart with Tradition: The Promise of the MUTTON-HF Program in the Navajo Nation
Cardiologyheart failurenutrition

Healing the Heart with Tradition: The Promise of the MUTTON-HF Program in the Navajo Nation

By MedXY|Feb 24, 2026

A groundbreaking clinical trial demonstrates that medically tailored meals featuring traditional Indigenous foods can significantly improve heart failure outcomes and food security in rural Navajo communities.

Beyond Blood Sugar: Why Insulin Resistance Drives Vagal Dysfunction in Heart Failure
Cardiologyautonomic functionheart failure

Beyond Blood Sugar: Why Insulin Resistance Drives Vagal Dysfunction in Heart Failure

By MedXY|Feb 4, 2026

Evidence from the Myovasc study reveals that insulin resistance and C-peptide levels are independent predictors of impaired cardiac vagal activity in heart failure, suggesting that metabolic health directly influences autonomic regulation b

Insulin Metabolism as a Primary Driver of Cardiac Autonomic Dysfunction in Heart Failure: Insights from the Myovasc Study
Cardiologyautonomic nervous systemheart failure

Insulin Metabolism as a Primary Driver of Cardiac Autonomic Dysfunction in Heart Failure: Insights from the Myovasc Study

By MedXY|Feb 3, 2026

The Myovasc study demonstrates that insulin resistance and secretion markers, rather than glucose levels alone, are independently associated with impaired cardiac vagal activity in heart failure patients, suggesting a metabolic-autonomic ax

AI-ECG Models for Heart Failure Screening Show High Accuracy in First-of-its-Kind Independent Comparison Study
AIartificial intelligenceCardiology

AI-ECG Models for Heart Failure Screening Show High Accuracy in First-of-its-Kind Independent Comparison Study

By MedXY|Jan 26, 2026

This independent validation study confirms that AI-enhanced ECG models effectively detect left ventricular systolic dysfunction across diverse populations, achieving AUROCs up to 0.93. However, significant barriers remain regarding model tr

Prev
5 / 9
1…34567…9
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities